ROCKWELL MEDICAL, INC.

For the period ended Aug 14, 2025. Filed Aug 14, 2025.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Aug 14, 2025 · Filed Aug 14, 2025

Use the contents to explore the available documents and sections.

RMTI$7.73+1.7%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

EX-99.1 · Adjusted EBITDA

Adjusted EBITDA

Adjusted EBITDA for the three months ended June 30, 2025 was ($0.2) million compared to Adjusted EBITDA of $1.4 million for the second quarter 2024. Adjusted EBITDA in the second quarter of 2025 represents a slight improvement over Adjusted EBITDA of ($0.4) million in the first quarter of 2025.

Adjusted EBITDA for the six months ended June 30, 2025 was ($0.7) million compared with Adjusted EBITDA of $0.9 million for the same period in 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.